Authors: Conner, AL Wray, H Cottrell, J Wilding, IR

Citation: Al. Conner et al., A scintigraphic study to investigate the potential for altered gut distribution of loperamide from a loperamide-simethicone formulation in man, EUR J PH SC, 13(4), 2001, pp. 369-374

Authors: Thomas, RR Dahut, W Harold, N Grem, JL Monahan, BP Liang, M Band, RA Cottrell, J Llorens, V Smith, JA Corse, W Arbuck, SG Wright, J Chen, AP Hamilton, JM Allegra, CJ Takimoto, CH

Citation: Rr. Thomas et al., A phase I and pharmacologic study of 9-aminocamptothecin administered as a120-h infusion weekly to adult cancer patients, CANC CHEMOT, 48(3), 2001, pp. 215-222

Authors: Guemei, AA Cottrell, J Band, R Hehman, H Prudhomme, M Pavlov, MV Grem, JL Ismail, AS Bowen, D Taylor, RE Takimoto, CH

Citation: Aa. Guemei et al., Human plasma carboxylesterase and butyrylcholinesterase enzyme activity: correlations with SN-38 pharmacokinetics during a prolonged infusion of irinotecan, CANC CHEMOT, 47(4), 2001, pp. 283-290

Authors: Forrest, I Tabbener, H Cottrell, J Connolly, T

Citation: I. Forrest et al., The genetic structures of a range of Douglas-fir provenance collections after planting in different European countries, assessed with two biochemicalmarker systems, BIOCH SYST, 29(8), 2001, pp. 769-792

Authors: Takimoto, CH Morrison, G Harold, N Quinn, M Monahan, BP Band, RA Cottrell, J Guemei, A Llorens, V Hehman, H Ismail, AS Flemming, D Gosky, DM Hirota, H Berger, SJ Berger, NA Chen, AP Shapiro, JD Arbuck, SG Wright, J Hamilton, JM Allegra, CJ Grem, JL

Citation: Ch. Takimoto et al., Phase I and pharmacologic study of irinotecan administered as a 96-hour infusion weekly to adult cancer patients, J CL ONCOL, 18(3), 2000, pp. 659-667